Post-stroke upper limb spasticity
Conditions
Interventions
Experimental group (TEAS group):Perform transcutaneous electrical acupoint stimulation on the acupuncture points of the affected upper limb.
Control group (fake TEAS group):Perform sham transcutaneous electroacupuncture on the acupuncture points of the upper limb on the affected side.
Sponsors
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
30 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Meets the diagnostic criteria for stroke; 1) Western medical diagnostic criteria: Refer to the diagnostic criteria for cerebral infarction in the "Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke" formulated by the Cerebrovascular Disease Group of the Neurology Branch of the Chinese Medical Association in 2018. All cases were confirmed by CT or MRI. 2) Traditional Chinese medical diagnostic criteria: Refer to the "Guidelines for the Diagnosis and Treatment of Common Internal Diseases in Traditional Chinese Medicine" issued by the Chinese Association of Traditional Chinese Medicine - stroke (ZYYXH/T22-2008) 2. Onset time within 1 to 12 months; 3. Possesses symptoms such as hemiplegia of the upper limb and increased muscle tone, with evaluation criteria based on Brunnstrom staging in the II~IV stages (spasticity phase) for upper limb spasticity, and 20 = FMA-UE = 50; 4. Age between 30 and 75 years old; 5. Stable vital signs, clear consciousness, no significant communication barriers, and basically normal cognitive function; 6. The patient or their family has signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with upper limb spasticity prior to this stroke episode 2. Patients with upper limb spasticity caused by other neurological disorders 3. Patients with other diseases such as rheumatoid arthritis, fractures, trauma, or joint diseases that affect limb motor function 4. Patients at high risk of recurrence or death 5. Patients with concomitant mental disorders or severe dysfunction of important organs such as heart, liver, or kidneys, or severe primary diseases of the hematopoietic or endocrine systems 6. Patients with contraindications for transcutaneous electrical acupoint stimulation (e.g., implanted electronic devices) or fear of the procedure, deemed by the physician to be at high risk of loss to follow-up 7. Patients with infection, ulcers, or scars at the acupuncture site 8. Pregnant or breastfeeding women 9. Patients who have received or are currently receiving electrical or magnetic stimulation therapy, muscle relaxants, or botulinum toxin A injections within the past 30 days, which may affect the assessment of this study's efficacy 10. Patients with contraindications for EEG/fNIRS, such as severe scalp trauma, extensive or open cranial injuries, inability to place electrodes, or risk of infection from the procedure; or patients who are extremely agitated and unable to be calmed to cooperate with the examination
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Upper limb Fugl-Meyer assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain Level;Severity of muscle spasm;Activities of Daily Living;Motor function;Muscle Function Level;Functional near-infrared spectroscopy;Electroencephalogram (EEG) ; | — |
Countries
China
Contacts
Public ContactLiu Jian
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Outcome results
None listed